ProModRx adds infrastructure and capabilities that strengthen D2's support from initial access through ongoing patient services

ProModRx 增加了基础设施和能力，加强了 D2 从初始访问到持续患者服务的支持。

SAINT CHARLES, Mo.

圣查尔斯，密苏里州

,

，

April 16, 2026

2026年4月16日

/PRNewswire/ --

/PRNewswire/ --

D2 Solutions

D2 解决方案

, a healthcare consulting and technology company focused on market access, reimbursement and patient support, has acquired

，一家专注于市场准入、报销和患者支持的医疗咨询和技术公司，已经收购了

ProModRx

ProModRx

, a cloud-based technology platform designed to help speed patient access to prescription medications.

，一个基于云技术的平台，旨在帮助加快患者获得处方药的速度。

The acquisition expands D2's services to better assist pharmaceutical and medical device manufacturers, traditional hubs and pharmacies across the full scope of the patient journey. That support includes therapy initiation, prescription capture, electronic benefits verification, prior authorization support, dispensing coordination and ongoing patient engagement..

此次收购扩展了D2的服务，以更好地协助制药和医疗器械制造商、传统中心以及患者旅程全范围内的药房。该支持包括治疗启动、处方捕获、电子福利验证、事先授权支持、配药协调以及持续的患者参与。

The need for stronger connectivity between manufacturers, prescribers and patients is significant.

制造商、开处方者和患者之间需要更强的连通性，这一点非常重要。

In recent D2 research

近年来的D2研究

, 21% of adults delayed starting a prescribed medication because of confusion or access issues. In addition, 11% of respondents did not pick up their medication from the pharmacy, 12% skipped doses and 8% stopped treatment earlier than planned.

，21% 的成年人因为困惑或获取问题而延迟开始服用处方药。此外，11% 的受访者没有从药房取药，12% 的人跳过了剂量，8% 的人比计划提前停止了治疗。

The deal also comes as healthcare stakeholders—especially patients, providers and manufacturers—face growing pressure to manage access, reimbursement and fulfillment amid a more complex

该协议达成之际，医疗保健行业的利益相关者——尤其是患者、医疗服务提供者和制造商——面临着越来越大的压力，需要在更加复杂的环境中管理获取途径、报销和履行。

pricing and policy environment

定价和政策环境

.

。

'D2's focus has always been responding to market demands and the needs of our partners by helping address gaps in market access, operational support and patient services,' said

“D2的重点一直是通过帮助解决市场准入、运营支持和患者服务方面的缺口，来响应市场需求和合作伙伴的需求，”

Dean Erhardt

迪恩·埃尔哈特

, D2 Founder and CEO. 'The integration of ProModRx expands our ability to deliver the services and infrastructure our industry—and their patients—are asking for. Together, we offer an ecosystem of solutions focused on helping patients start therapy faster and with fewer barriers.

，D2创始人兼首席执行官。“ProModRx的整合扩展了我们提供行业及患者所需的服务和基础设施的能力。通过合作，我们提供了一个专注于帮助患者更快开始治疗且减少障碍的解决方案生态系统。”

'

'

The acquisition strengthens the capabilities D2 brings to clients through its UltraTouch

此次收购加强了D2通过其UltraTouch为客户带来的能力。

®

®

Verify and UltraTouch

验证并超触控

®

®

Engage offerings:

参与提供：

UltraTouch Verify

超触控验证

reduces therapy delays through:

通过以下方式减少治疗延误：

Patient and drug-specific electronic Benefit Verification (eBV) for both medical and pharmacy benefits

患者和药物特定的电子福利验证（eBV），适用于医疗和药房福利

Comprehensive coverage insights across all therapy types

覆盖所有治疗类型的综合见解

Prior authorization workflows

事先授权工作流程

Prescriber-input collection

处方者输入收集

Automated appeals workflows

自动化上诉工作流程

UltraTouch Engage

超触感参与

connects with patients earlier and keeps them engaged through therapy with:

通过以下方式与患者更早建立联系，并在治疗过程中保持他们的参与：

Automated outreach

自动化推广

Enrollment and onboarding support

注册和入职支持

Multilingual digital communication

多语言数字通信

The deal strengthens D2's support for pharmaceutical and medical device manufacturers that depend on reimbursement support, enrollment and product access coordination and extends its offering across retail, hospital, mail-order and specialty pharmacy channels.

该交易加强了D2对依赖报销支持、注册和产品获取协调的制药和医疗器械制造商的支持，并将其服务扩展到零售、医院、邮购和专业药房渠道。

As part of the acquisition, ProModRx employees will continue to support the business.

作为收购的一部分，ProModRx 的员工将继续为该业务提供支持。

Jerry Smith

杰瑞·史密斯

, ProModRx's General Manager, will be joining D2 Solutions' executive team.

，ProModRx的总经理，将加入D2 Solutions的执行团队。

'D2 has been a respected name in this industry for nearly two decades,' said Smith. 'ProModRx's technology and services are a natural fit for D2's UltraTouch Engage and Verify offerings. Together, we can offer our shared clients a broader and deeper set of solutions that support enrollment, reimbursement, fulfillment and ongoing engagement all within a single, integrated model.'.

“D2 在这一行业近二十年来一直是一个受人尊敬的名字，”史密斯说。“ProModRx 的技术和服 务与 D2 的 UltraTouch Engage 和 Verify 产品线非常契合。我们共同为共享客户在单一集成 模型内提供更广泛、更深入的解决方案，支持注册、报销、履行和持续参与。”

The acquisition supports D2's focus on providing a modular, connected patient service model that supports multiple industry stakeholders.

该收购支持了D2专注于提供模块化、互联的患者服务模式，该模式支持多个行业利益相关者。

'This acquisition is an important step,' said Erhardt. 'It brings together the services and infrastructure our clients need to connect enrollment, reimbursement, fulfillment and ongoing engagement more effectively—ultimately creating a better experience for patients.'

“这次收购是一个重要的步骤，”埃尔哈特说。“它将我们客户所需的连接注册、报销、履行和持续参与的服务和基础设施整合在一起——最终为患者创造更好的体验。”

D2 Solutions will be available to discuss the ProModRx technology integration at

D2 Solutions 将可讨论 ProModRx 技术集成

Asembia's AXS26 Summit

阿森比亚的AXS26峰会

in Las Vegas, April 26-30. To learn more, visit Booth #2014 or

在拉斯维加斯，4月26日至30日。欲了解更多信息，请访问2014号展位或

d2rx.com/axs26

d2rx.com/axs26

.

。

About D2 Solutions

关于D2解决方案

D2 Solutions is a healthcare and pharma commercialization partner focused on accelerating patient access to therapy. By combining strategic advisory services with proprietary technology, D2 Solutions works to reduce friction between manufacturers, pharmacies and payers. From streamlining market access and prior authorization to supporting regulatory compliance and accreditation, the D2 Solutions platform is designed to optimize the specialty drug lifecycle and help patients access the therapies they need.

D2 Solutions 是一家专注于加速患者获得治疗的医疗和制药商业化合作伙伴。通过将战略咨询服务与专有技术相结合，D2 Solutions 致力于减少制造商、药房和支付方之间的摩擦。从简化市场准入和预先授权，到支持法规合规性和认证，D2 Solutions 平台旨在优化特种药物生命周期，并帮助患者获得所需的治疗。

Learn more at .

了解更多，请访问。

d2rx.com

d2rx.com

.

。

Media Contact

媒体联系人

PANBlast PR for D2 Solutions

PANBlast 公共关系（PR）为 D2 解决方案

[email protected]

电子邮件地址

SOURCE D2 Solutions

来源 D2 解决方案

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示